trial · primary record
SOC plus 15mg/kg EB05 IV
COVID-19
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 278 |
| Primary completion | 2024-07-22 |
| Primary endpoint | Mortality rate at Day 28 from IP administration. (Phase 2 and 3) |
| Registry ID | NCT04401475 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:30:46.884Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04401475
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.